Human T-cell Leukemia Virus Type 1 - 25 Studies Found
Recruiting |
: Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1 : HTLV-I Infections : 2012-12-14 |
Recruiting |
: Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load : Human T-cell Leukemia Virus Type 1 Infection : 2012-01-25 : Drug: Raltegravir Raltegravir 400 mg po bid |
Recruiting |
: Raltegravir for HAM/TSP : HTLV-I Infection : 2013-05-21 : Drug: Raltegravir |
Recruiting |
: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis : HTLV-1 : 2006-07-12 : Drug: Hu MiK-Beta-1 |
Completed |
: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial : HTLV-I-associated Myelopathy : 2006-01-04 : Drug: Zidovudine/lamivudine |
Completed |
: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV-I-Associated Myelopathy : 2011-04-25 : Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Enrolling by invitation |
: Urological Physical Therapy in HTLV-1 With Urinary Symptoms :
: 2012-07-25 : Procedure: Urological physical therapy Individual patient attending with one hour duration beginning wit |
Not yet recruiting |
: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection :
: 2015-11-16 : Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |
Completed |
: Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) :
|